Clinical Trial: ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals
Study Status: Completed
Recruit Status: RECRUITING
Condition: Immunodeficiency
Study Type: INTERVENTIONAL
Official Title: ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals
Brief Summary:
The investigators will examine whether a combination of at-home nucleic acid amplification tests, on-demand telemedicine, and delivery of prescriptions such as Paxlovid quickly after testing positive for COVID-19, can reduce severe outcomes and hospitalization of immunocompromised patients and those who are 65 years and older.They will also analyze whether these efforts lower the cost of care compared to standard of care.
Read more